go back

New Jersey rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $851,138 · 10th–90th $16,982–$1,513,5610%20%10th90th$851,138Professionalmedian $562,341 · 10th–90th $562,341–$758,5780%50%90th$562,341$200.0$1.0K$5.0K$20.0K$100.0K$500.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$707,945.78 / $851,138.04 / $1,905,460.72
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $758,577.58
Horizon BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$1,995.26 / $16,218.10 / $1,380,384.26
Horizon BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $524,807.46 / $537,031.80
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$426,579.52 / $645,654.23 / $1,122,018.45
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $524,807.46 / $630,957.34